Skip to content

mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention

mLab App Plus: A Randomized Controlled Trial of an mHealth Intervention for Increasing Access to HIV and Syphilis Testing and Care Among Young Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06059443
Enrollment
40
Registered
2023-09-28
Start date
2023-10-17
Completion date
2024-06-21
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Sexually Transmitted Diseases, Viral, Syphilis

Brief summary

Men who have sex with men (MSM), especially young men who have sex with men (YMSM), and transgender women (TGW) have some of the highest rates of HIV and syphilis diagnoses in the United States. The goal of this study is to pilot the mobile Lab (mLab) App Plus to assess YMSM's and YTGW's abilities to perform and interpret self-tests for HIV and syphilis and consequently increase the number of YMSM and young transgender woman (YTGW) who initiate self-testing for HIV and syphilis.

Detailed description

From 2018 to 2019, the rate of syphilis increased by 11.2%. It has increased steadily since 2000 especially among men, in which MSM bear a disproportionate majority of cases (47% of all cases were among MSM in 2019). HIV and syphilis rates continue to rise among YMSM. While MSM account for only about 2% of the US population, they are most affected by HIV, constituting 56% of people living with HIV (PLWH). Moreover, the rate of syphilis among MSM is profoundly elevated, at least 100 times higher than that in men who have sex with women and even higher among YMSM. Importantly, syphilis makes it easier to both acquire and transmit HIV, and about half of MSM who have syphilis are co-infected with HIV. The risk of syphilis and HIV continues to rise in YMSM in New York City, the study site. Given these epidemiologic risk factors for HIV and syphilis, there is a strong scientific premise for this pilot study that proposes to test innovative and effective HIV and sexually transmitted infection (STI) testing, prevention, and treatment models. Given that approximately 17% of MSM living with HIV in the U.S. are unaware of their status and significant comorbid syphilis in that population, both pathogens may be simultaneously transmitted. The increasing number of syphilis diagnosed in MSM highlights the importance of STI control in this population, not just for the health of the patient, but also for prevention of HIV and syphilis in uninfected persons. YMSM and YTGW, and specifically Blacks and Latinos, are disproportionately infected with HIV. In response to the need for interventions to increase HIV testing in youth, our study team developed the mLab App, which affords advantages over existing self-test options to support the potential for higher uptake of the HIV self-test. The app provides HIV prevention information, push notification reminders for testing, step-by-step instructions for using the OraQuick HIV tests (OraQuick), and an image upload function so individuals can send an image of their OraQuick HIV test to the study team. In response to the mLab App study and the scientific evidence of need for at-home syphilis point of care (POC) testing among YMSM and YTGW, we propose to implement the mLab App Plus to assess YMSM's and YTGW's abilities to perform and interpret self-tests for HIV and syphilis and consequently increase the number of YMSM and YTGW who initiate self-testing for HIV and syphilis.

Interventions

BEHAVIORALmLab App Plus

Participants will use the mLab Plus app to test for Syphilis and HIV using the DPP HIV/Syphilis Test

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
National Institute of Mental Health (NIMH)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

Participants will be randomly assigned to one of two trial arms using the randomization module in REDCap. We will use block randomization with randomly permutated blocks to reduce opportunities for selection bias

Eligibility

Sex/Gender
MALE
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-39 years of age * Assigned male sex at birth and identify as (1) a man or (2) a trans woman * Understand and read English * Self-identify as any race or ethnicity * Substantial risk for acquiring HIV infection per CDC (Centers for Disease Control) guidance * All participants must report having sex with a man/men * Smart phone ownership * Self-report being HIV-negative or unknown status * Self-report being negative for syphilis or unknown status * Not having been tested for HIV or syphilis in the past 3 months * Understand the limitations of the duplex lateral flow test and the mLab App Plus (e.g., a confirmatory test is needed and self-test must be performed in the presence of a qualified clinician)

Design outcomes

Primary

MeasureTime frameDescription
The Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App Plus3-Month Follow-upA successful self-test is defined as having completed the DPP® HIV-Syphilis test by themselves and having accurately identified and interpreted their HIV and Syphilis statuses as determined by the supervising clinician. In the event that the clinician, rather than the participant administers the DPP® HIV-Syphilis test, the test is not recorded as a successful self-test.

Secondary

MeasureTime frameDescription
The Number of Negative/Positive Results3-Month Follow-upThe number of participants who tested reactive (R) or positive and/or non-reactive (NR) or negative for syphilis and HIV using the DPP® HIV-Syphilis test with mLab App Plus. Test results appear in a single reading with the results of both HIV and syphilis.
Number of Participants Referred for HIV/STI Services (Participants With HIV and/or Syphilis Only)3-Month Follow-upThe number of Young Men who have sex with men/ Young transgender women referred for HIV/STI services (participants with HIV and/or syphilis only). Using count of referral for participants that tested positive (reactive) to HIV and/or syphilis using mLabApp Plus.
Number of Participants Linked to (Attend One Appointment) HIV/STI Prevention or Care Services3-Month Follow-upThe number of Young Men who have sex with men/ Young transgender women linked to (attend one appointment) HIV/STI prevention or care services. Using count of appointments attended.

Countries

United States

Participant flow

Participants by arm

ArmCount
mLab App Plus
Participants randomized to intervention will receive standard of care counseling, complete online surveys, be provided with the mLab App Plus, and a box of condoms. The intervention arm will also complete two HIV/Syphilis Ab Combo Rapid Tests (DPP® HIV-Syphilis Test) at their baseline (first test) and 3-month follow- up (second test) appointments. mLab App Plus: Participants will use the mLab Plus app to test for Syphilis and HIV using the DPP HIV/Syphilis Test
20
Standard of Care
Participants randomized to standard care will receive standard of care counseling, complete online surveys and be sent an email with links to mobile-optimized online prevention information, including Pre-Exposure Prophylaxis(PrEP) and HIV/STI testing information found on the Centers for Disease Control (CDC) website, and a box of condoms.
20
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up22
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicmLab App PlusTotalStandard of Care
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
20 Participants40 Participants20 Participants
Age, Continuous28.33 years
STANDARD_DEVIATION 3.94
28.52 years
STANDARD_DEVIATION 4.45
28.71 years
STANDARD_DEVIATION 4.99
Number of Participants Linked to HIV/STI Prevention or Care Services2 Participants2 Participants
Number of Participants referred for HIV/STI Services5 Participants5 Participants
Race/Ethnicity, Customized
Race
Asian
5 Participants7 Participants2 Participants
Race/Ethnicity, Customized
Race
Black or African American
5 Participants9 Participants4 Participants
Race/Ethnicity, Customized
Race
Native Hawaiian or Other Pacific Islander
0 Participants2 Participants2 Participants
Race/Ethnicity, Customized
Race
Unknown
2 Participants6 Participants4 Participants
Race/Ethnicity, Customized
Race
White
8 Participants16 Participants8 Participants
Region of Enrollment
United States
20 participants40 participants20 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
20 Participants40 Participants20 Participants
The Number of Negative/Positive Results
Negative (HIV)/ Negative (Syphilis)
15 Participants15 Participants
The Number of Negative/Positive Results
Negative (HIV)/ Positive (Syphilis)
3 Participants3 Participants
The Number of Negative/Positive Results
Positive (HIV)/ Negative (Syphilis)
1 Participants1 Participants
The Number of Negative/Positive Results
Positive (HIV)/ Positive (Syphilis)
1 Participants1 Participants
The Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App16 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

The Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App Plus

A successful self-test is defined as having completed the DPP® HIV-Syphilis test by themselves and having accurately identified and interpreted their HIV and Syphilis statuses as determined by the supervising clinician. In the event that the clinician, rather than the participant administers the DPP® HIV-Syphilis test, the test is not recorded as a successful self-test.

Time frame: 3-Month Follow-up

Population: The Standard of Care arm did not receive access to the mLab App Plus.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
mLab App PlusThe Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App Plus12 Participants
Secondary

Number of Participants Linked to (Attend One Appointment) HIV/STI Prevention or Care Services

The number of Young Men who have sex with men/ Young transgender women linked to (attend one appointment) HIV/STI prevention or care services. Using count of appointments attended.

Time frame: 3-Month Follow-up

Population: Three analyzed as three participants tested positive at month 3

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
mLab App PlusNumber of Participants Linked to (Attend One Appointment) HIV/STI Prevention or Care Services0 Participants
Secondary

Number of Participants Referred for HIV/STI Services (Participants With HIV and/or Syphilis Only)

The number of Young Men who have sex with men/ Young transgender women referred for HIV/STI services (participants with HIV and/or syphilis only). Using count of referral for participants that tested positive (reactive) to HIV and/or syphilis using mLabApp Plus.

Time frame: 3-Month Follow-up

Population: Three analyzed as three tested positive using the mLabApp Plus. The Standard of Care arm did not receive access to the mLab App Plus.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
mLab App PlusNumber of Participants Referred for HIV/STI Services (Participants With HIV and/or Syphilis Only)3 Participants
Secondary

The Number of Negative/Positive Results

The number of participants who tested reactive (R) or positive and/or non-reactive (NR) or negative for syphilis and HIV using the DPP® HIV-Syphilis test with mLab App Plus. Test results appear in a single reading with the results of both HIV and syphilis.

Time frame: 3-Month Follow-up

Population: 15 participants analyzed in the mLab App Plus arm as data was collected from 15 out of 20 (n=4 did not complete the 3-month follow up and a sample was not collected for n=1). The Standard of Care arm did not receive access to the mLab App Plus.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
mLab App PlusThe Number of Negative/Positive ResultsNegative (HIV) / Negative (Syphilis)12 Participants
mLab App PlusThe Number of Negative/Positive ResultsNegative (HIV) / Positive (Syphilis)3 Participants
mLab App PlusThe Number of Negative/Positive ResultsPositive (HIV) / Negative (Syphilis)0 Participants
mLab App PlusThe Number of Negative/Positive ResultsPositive (HIV) /Positive (Syphilis)0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026